Free Trial

Sapiens International (SPNS) Financials

Sapiens International logo
$28.14 +0.53 (+1.92%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$28.12 -0.03 (-0.09%)
As of 05:23 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Sapiens International

Annual Income Statements for Sapiens International

This table shows Sapiens International's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Income / (Loss) Attributable to Common Shareholders
72 62 53 47 34 26 14 0.35 19 20 14
Consolidated Net Income / (Loss)
72 63 53 47 34 26 14 0.56 20 20 15
Net Income / (Loss) Continuing Operations
72 63 53 47 34 26 14 0.56 20 20 15
Total Pre-Tax Income
90 77 66 57 41 35 19 -2.01 25 25 15
Total Operating Income
86 79 66 57 45 38 23 1.00 25 24 15
Total Gross Profit
238 220 200 188 156 130 110 94 86 74 58
Total Revenue
542 515 475 461 383 326 290 269 216 186 157
Operating Revenue
542 515 475 461 383 326 290 269 216 186 157
Total Cost of Revenue
304 295 275 273 227 196 180 176 130 111 99
Operating Cost of Revenue
304 295 275 273 227 196 180 176 130 111 99
Total Operating Expenses
152 141 134 130 111 92 87 93 61 50 43
Selling, General & Admin Expense
86 77 75 76 70 54 52 61 44 40 32
Research & Development Expense
66 63 59 54 41 37 34 32 16 10 11
Total Other Income / (Expense), net
3.98 -1.75 -0.94 -0.20 -3.81 -2.77 -3.99 -3.01 0.53 0.16 0.12
Other Income / (Expense), net
3.98 -1.75 -0.94 -0.20 -3.81 -2.77 -3.99 -3.01 0.53 - 0.12
Income Tax Expense
18 14 13 9.96 7.04 8.61 5.03 -2.56 5.77 4.21 0.45
Net Income / (Loss) Attributable to Noncontrolling Interest
0.14 0.42 0.34 0.15 0.38 0.24 0.22 0.20 0.27 0.28 0.11
Basic Earnings per Share
$1.29 $1.13 $0.95 $0.86 $0.67 $0.53 $0.28 $0.01 $0.40 $0.42 $0.31
Weighted Average Basic Shares Outstanding
55.89M 55.73M 55.14M 55.07M 54.66M 50.16M 0.00 49.76M 49.04M 48.76M 47.68M
Diluted Earnings per Share
$1.29 $1.12 $0.95 $0.85 $0.65 $0.52 $0.28 $0.01 $0.40 $0.41 $0.30
Weighted Average Diluted Shares Outstanding
55.89M 55.73M 55.14M 55.07M 54.66M 50.16M 0.00 49.76M 49.04M 48.76M 47.68M
Weighted Average Basic & Diluted Shares Outstanding
55.89M 55.73M 55.14M 55.07M 54.66M 50.16M 0.00 49.76M 49.04M 48.76M 47.68M

Quarterly Income Statements for Sapiens International

No quarterly income statements for Sapiens International are available.


Annual Cash Flow Statements for Sapiens International

This table details how cash moves in and out of Sapiens International's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Change in Cash & Equivalents
37 -34 -30 38 86 27 -6.84 11 5.16 6.95 -23
Net Cash From Operating Activities
82 79 44 81 58 66 28 9.25 26 40 22
Net Cash From Continuing Operating Activities
82 79 44 81 58 66 28 12 26 40 22
Net Income / (Loss) Continuing Operations
72 63 53 47 34 26 14 0.56 20 20 15
Consolidated Net Income / (Loss)
72 63 53 47 34 26 14 0.56 20 20 15
Depreciation Expense
4.37 3.87 4.24 29 23 19 20 16 10 9.63 8.72
Amortization Expense
0.04 18 0.09 0.11 - - - 0.51 -0.52 -0.45 -0.23
Non-Cash Adjustments To Reconcile Net Income
15 3.82 14 6.09 4.52 1.54 2.29 2.04 1.72 1.19 1.07
Changes in Operating Assets and Liabilities, net
-9.50 -8.76 -28 -1.65 -3.80 19 -8.30 -6.59 -4.79 9.78 -2.58
Net Cash From Investing Activities
13 -73 -12 0.13 -128 -42 -26 -73 -9.71 -19 -43
Net Cash From Continuing Investing Activities
13 -73 -13 0.13 -128 -19 -26 -73 -9.71 -19 -43
Purchase of Property, Plant & Equipment
-3.00 -2.57 -3.03 -3.79 -2.63 -11 -1.91 -2.62 -10 -8.85 -7.56
Acquisitions
-7.51 -15 -9.56 -7.08 -5.80 -5.67 -5.16 -106 -4.38 -2.93 -2.06
Sale of Property, Plant & Equipment
0.20 0.05 0.05 1.11 0.01 0.83 0.00 0.00 - - -
Sale and/or Maturity of Investments
-139 - -55 - - - - 35 14 1.50 1.54
Other Investing Activities, net
162 60 55 9.88 20 -1.12 0.00 0.00 - -0.89 0.24
Net Cash From Financing Activities
-56 -43 -58 -40 157 -21 -9.43 70 -11 -14 1.46
Net Cash From Continuing Financing Activities
-56 -43 -58 -40 157 -21 -9.43 70 -11 -14 1.46
Repayment of Debt
-20 -20 -20 -20 -30 -9.90 -0.24 -0.06 -0.82 0.00 0.00
Payment of Dividends
-36 -28 -39 -21 -7.04 -11 -10 -9.85 -9.86 -7.26 -0.11
Other Financing Activities, net
-0.53 4.81 0.00 1.11 4.37 0.41 0.83 1.69 -0.55 -6.91 1.57
Other Net Changes in Cash
-2.75 - -6.39 - - - - - - - -
Cash Interest Paid
1.04 0.75 1.47 3.50 5.44 2.48 2.07 0.71 0.05 0.01 0.01
Cash Income Taxes Paid
26 30 13 9.05 16 6.40 2.85 2.71 1.20 2.23 0.67

Quarterly Cash Flow Statements for Sapiens International

No quarterly cash flow statements for Sapiens International are available.


Annual Balance Sheets for Sapiens International

This table presents Sapiens International's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Total Assets
692 690 668 715 714 452 379 374 258 242 233
Total Current Assets
335 315 285 300 267 147 130 131 120 98 83
Cash & Equivalents
164 127 160 190 153 66 65 71 61 54 47
Short-Term Investments
53 75 20 20 30 23 0.00 - 18 8.78 0.00
Accounts Receivable
100 90 93 76 65 50 59 53 35 30 32
Prepaid Expenses
19 23 12 14 19 7.82 6.22 6.28 6.39 5.46 3.96
Plant, Property, & Equipment, net
11 13 12 14 17 17 8.52 11 9.81 5.68 5.01
Total Noncurrent Assets
346 362 371 400 430 289 240 232 128 138 145
Goodwill
252 256 252 261 264 171 166 159 74 70 68
Intangible Assets
51 61 67 82 99 58 65 65 28 28 28
Noncurrent Deferred & Refundable Income Taxes
13 11 9.42 3.12 - - - - - - -
Other Noncurrent Operating Assets
30 34 42 54 66 60 8.99 8.22 8.66 9.80 16
Total Liabilities & Shareholders' Equity
692 690 668 715 714 452 379 374 258 242 233
Total Liabilities
212 240 265 306 330 227 176 171 63 60 55
Total Current Liabilities
150 149 146 152 145 105 81 70 48 47 40
Short-Term Debt
20 20 20 20 20 9.90 9.90 0.00 - - -
Accounts Payable
8.41 6.29 9.42 5.01 5.39 5.11 6.15 7.04 6.56 4.72 3.31
Accrued Expenses
28 29 35 33 35 34 25 24 14 15 12
Current Deferred Revenue
38 39 31 40 35 21 18 17 9.14 10 9.27
Current Employee Benefit Liabilities
49 49 42 43 40 27 22 23 18 17 15
Other Current Liabilities
6.44 6.62 9.06 11 9.92 8.31 0.00 - - - -
Total Noncurrent Liabilities
62 91 119 154 185 122 95 101 15 13 15
Long-Term Debt
20 40 59 79 99 59 69 78 0.00 - -
Noncurrent Deferred & Payable Income Tax Liabilities
6.90 11 11 15 16 5.08 12 9.17 2.17 - -
Other Noncurrent Operating Liabilities
36 40 49 60 70 58 15 14 13 13 15
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
480 450 403 409 384 225 202 201 194 182 178
Total Preferred & Common Equity
480 447 401 407 382 224 201 200 194 181 178
Total Common Equity
480 447 401 407 382 224 201 200 194 181 178
Common Stock
356 354 345 342 335 218 216 222 227 235 250
Retained Earnings
160 120 86 72 45 18 2.67 -13 -13 -33 -53
Accumulated Other Comprehensive Income / (Loss)
-27 -17 -21 2.82 11 -2.38 -7.82 0.53 -11 -12 -10
Other Equity Adjustments
-9.42 -9.42 -9.42 - - - - - - - -
Noncontrolling Interest
0.00 2.68 2.35 2.17 2.00 1.68 1.44 0.83 0.80 0.87 0.69

Quarterly Balance Sheets for Sapiens International

No quarterly balance sheets for Sapiens International are available.


Annual Metrics And Ratios for Sapiens International

This table displays calculated financial ratios and metrics derived from Sapiens International's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Growth Metrics
- - - - - - - - - - -
Revenue Growth
5.40% 8.39% 2.97% 20.41% 17.57% 12.42% 7.62% 24.52% 16.46% 17.90% 16.30%
EBITDA Growth
-4.44% 41.14% -18.81% 33.26% 19.07% 39.46% 170.62% -58.79% 4.05% 42.51% 15.93%
EBIT Growth
16.48% 17.65% 14.43% 39.05% 17.37% 84.44% 1,047.76% -107.91% 4.20% 62.01% 21.18%
NOPAT Growth
7.50% 19.75% 13.06% 27.28% 30.55% 68.75% 2,314.59% -96.34% -4.84% 39.49% 30.16%
Net Income Growth
15.04% 18.77% 11.85% 38.54% 28.94% 89.22% 2,417.99% -97.16% -3.44% 39.27% 25.74%
EPS Growth
15.18% 17.89% 11.76% 30.77% 25.00% 85.71% 2,700.00% -97.50% -2.44% 36.67% 11.11%
Operating Cash Flow Growth
3.53% 81.42% -45.64% 38.26% -11.94% 138.83% 199.52% -64.48% -35.61% 87.56% 24.88%
Free Cash Flow Firm Growth
24.48% 19.32% -29.79% 190.36% -295.10% 313.13% 108.82% -1,396.44% -71.80% 80.32% 4,049.17%
Invested Capital Growth
-1.35% 1.80% 1.47% -7.11% 56.11% -5.21% 3.49% 111.27% 12.19% -9.97% -2.14%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
43.90% 42.67% 42.16% 40.74% 40.73% 39.77% 37.82% 34.74% 39.68% 40.10% 37.06%
EBITDA Margin
17.38% 19.17% 14.72% 18.67% 16.87% 16.65% 13.42% 5.34% 16.13% 18.06% 14.94%
Operating Margin
15.83% 15.33% 14.01% 12.47% 11.75% 11.63% 7.95% 0.37% 11.49% 13.12% 9.47%
EBIT Margin
16.56% 14.99% 13.81% 12.43% 10.76% 10.78% 6.57% -0.75% 11.74% 13.12% 9.55%
Profit (Net Income) Margin
13.33% 12.22% 11.15% 10.26% 8.92% 8.13% 4.83% 0.21% 9.07% 10.94% 9.26%
Tax Burden Percent
80.51% 81.52% 80.75% 82.61% 82.91% 75.47% 73.56% -27.69% 77.25% 82.81% 96.98%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.67% 100.00%
Effective Tax Rate
19.49% 18.48% 19.25% 17.39% 17.09% 24.53% 26.44% 0.00% 22.75% 17.19% 3.02%
Return on Invested Capital (ROIC)
22.65% 21.12% 17.92% 15.38% 14.21% 13.56% 7.96% 0.46% 20.51% 21.67% 14.60%
ROIC Less NNEP Spread (ROIC-NNEP)
20.65% 22.29% 18.64% 15.57% 21.67% 76.96% -20.46% 0.78% 20.08% 21.51% 14.44%
Return on Net Nonoperating Assets (RNNOA)
-7.09% -6.38% -4.88% -3.45% -3.00% -1.19% -1.04% -0.18% -10.12% -10.41% -6.24%
Return on Equity (ROE)
15.56% 14.74% 13.04% 11.93% 11.20% 12.38% 6.92% 0.28% 10.38% 11.26% 8.36%
Cash Return on Invested Capital (CROIC)
24.01% 19.33% 16.47% 22.75% -29.61% 18.91% 4.54% -71.04% 9.02% 32.15% 16.76%
Operating Return on Assets (OROA)
13.01% 11.36% 9.48% 8.02% 7.06% 8.45% 5.06% -0.64% 10.15% 10.24% 6.60%
Return on Assets (ROA)
10.47% 9.26% 7.65% 6.62% 5.86% 6.37% 3.72% 0.18% 7.84% 8.54% 6.40%
Return on Common Equity (ROCE)
15.52% 14.65% 12.97% 11.86% 11.13% 12.29% 6.86% 0.28% 10.30% 11.19% 8.32%
Return on Equity Simple (ROE_SIMPLE)
15.08% 14.06% 13.22% 11.64% 8.95% 11.84% 6.96% 0.28% 10.12% 11.22% 8.21%
Net Operating Profit after Tax (NOPAT)
69 64 54 47 37 29 17 0.70 19 20 14
NOPAT Margin
12.74% 12.49% 11.31% 10.30% 9.74% 8.78% 5.85% 0.26% 8.88% 10.86% 9.18%
Net Nonoperating Expense Percent (NNEP)
2.01% -1.17% -0.71% -0.19% -7.46% -63.40% 28.42% -0.32% 0.43% 0.15% 0.16%
Return On Investment Capital (ROIC_SIMPLE)
13.31% 12.62% 11.14% - - - - - - - -
Cost of Revenue to Revenue
56.10% 57.33% 57.84% 59.26% 59.27% 60.23% 62.18% 65.26% 60.32% 59.90% 62.94%
SG&A Expenses to Revenue
15.85% 15.01% 15.80% 16.56% 18.18% 16.67% 18.00% 22.50% 20.57% 21.47% 20.39%
R&D to Revenue
12.22% 12.34% 12.36% 11.72% 10.80% 11.48% 11.88% 11.87% 7.63% 5.51% 7.21%
Operating Expenses to Revenue
28.07% 27.35% 28.16% 28.27% 28.98% 28.14% 29.87% 34.37% 28.19% 26.99% 27.60%
Earnings before Interest and Taxes (EBIT)
90 77 66 57 41 35 19 -2.01 25 24 15
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
94 99 70 86 65 54 39 14 35 34 24
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.09 3.51 2.45 4.41 3.78 4.78 2.52 2.57 3.23 2.36 1.65
Price to Tangible Book Value (P/TBV)
8.36 12.08 12.13 28.31 79.80 0.00 0.00 0.00 6.81 5.12 3.57
Price to Revenue (P/Rev)
2.73 3.05 2.07 3.88 3.77 3.29 1.75 1.91 2.89 2.30 1.86
Price to Earnings (P/E)
20.53 25.13 18.64 37.97 42.75 40.77 36.78 1,457.81 32.30 21.33 20.26
Dividend Yield
2.12% 1.79% 3.93% 1.56% 1.25% 1.95% 3.93% 1.91% 1.56% 1.68% 0.00%
Earnings Yield
4.87% 3.98% 5.36% 2.63% 2.34% 2.45% 2.72% 0.07% 3.10% 4.69% 4.94%
Enterprise Value to Invested Capital (EV/IC)
4.31 4.65 2.92 5.66 4.32 5.13 2.41 2.50 5.36 3.79 2.18
Enterprise Value to Revenue (EV/Rev)
2.41 2.78 1.86 3.65 3.61 3.23 1.80 1.94 2.45 1.80 1.36
Enterprise Value to EBITDA (EV/EBITDA)
13.85 14.49 12.62 19.54 21.40 19.38 13.43 36.33 15.19 9.97 9.07
Enterprise Value to EBIT (EV/EBIT)
14.53 18.53 13.45 29.36 33.55 29.95 27.44 0.00 20.88 13.73 14.19
Enterprise Value to NOPAT (EV/NOPAT)
18.88 22.23 16.42 35.41 37.04 36.78 30.84 744.43 27.61 16.57 14.76
Enterprise Value to Operating Cash Flow (EV/OCF)
15.87 17.99 20.14 20.88 23.73 15.89 18.86 56.46 20.35 8.26 9.89
Enterprise Value to Free Cash Flow (EV/FCFF)
17.81 24.28 17.88 23.94 0.00 26.38 54.15 0.00 62.80 11.17 12.85
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.08 0.13 0.20 0.24 0.31 0.30 0.39 0.39 0.00 0.00 0.00
Long-Term Debt to Equity
0.04 0.09 0.15 0.19 0.26 0.26 0.34 0.39 0.00 0.00 0.00
Financial Leverage
-0.34 -0.29 -0.26 -0.22 -0.14 -0.02 0.05 -0.23 -0.50 -0.48 -0.43
Leverage Ratio
1.49 1.59 1.70 1.80 1.91 1.94 1.86 1.59 1.32 1.32 1.31
Compound Leverage Factor
1.49 1.59 1.70 1.80 1.91 1.94 1.86 1.59 1.32 1.33 1.31
Debt to Total Capital
7.62% 11.65% 16.40% 19.46% 23.57% 23.36% 27.93% 27.91% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
3.81% 3.89% 4.11% 3.90% 3.94% 3.36% 3.52% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
3.81% 7.76% 12.30% 15.56% 19.63% 20.00% 24.41% 27.91% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.53% 0.51% 0.45% 0.50% 0.57% 0.51% 0.78% 0.87% 0.69% 0.48%
Common Equity to Total Capital
92.38% 87.82% 83.09% 80.09% 75.93% 76.07% 71.56% 71.31% 99.13% 99.31% 99.52%
Debt to EBITDA
0.42 0.60 1.13 1.15 1.83 1.27 2.02 5.45 0.00 0.00 0.00
Net Debt to EBITDA
-1.87 -1.45 -1.45 -1.30 -0.99 -0.38 0.36 0.47 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.21 0.40 0.85 0.92 1.53 1.09 1.76 5.45 0.00 0.00 0.00
Debt to NOPAT
0.57 0.92 1.47 2.08 3.18 2.41 4.63 111.61 0.00 0.00 0.00
Net Debt to NOPAT
-2.56 -2.22 -1.89 -2.35 -1.72 -0.72 0.82 9.71 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.29 0.62 1.10 1.66 2.64 2.06 4.05 111.61 0.00 0.00 0.00
Altman Z-Score
6.05 5.58 3.68 4.81 3.65 3.97 2.82 2.65 7.42 5.43 4.01
Noncontrolling Interest Sharing Ratio
0.29% 0.60% 0.58% 0.60% 0.69% 0.73% 0.90% 0.98% 0.78% 0.58% 0.43%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.24 2.11 1.95 1.98 1.85 1.40 1.60 1.87 2.52 2.09 2.10
Quick Ratio
2.11 1.96 1.88 1.89 1.71 1.33 1.53 1.78 2.38 1.98 2.00
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
73 59 49 70 -78 40 9.65 -109 8.44 30 17
Operating Cash Flow to CapEx
2,937.66% 3,144.30% 1,473.58% 3,010.92% 2,222.63% 621.78% 1,447.23% 352.71% 255.06% 457.10% 285.12%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.79 0.76 0.69 0.65 0.66 0.78 0.77 0.85 0.86 0.78 0.69
Accounts Receivable Turnover
5.71 5.60 5.60 6.51 6.62 5.95 5.16 6.12 6.71 6.03 5.67
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
46.52 41.70 35.86 29.34 22.81 25.93 30.16 26.26 27.93 34.74 30.65
Accounts Payable Turnover
41.38 37.56 38.07 52.55 43.24 34.85 27.31 25.82 23.11 27.69 20.17
Days Sales Outstanding (DSO)
63.89 65.13 65.21 56.08 55.11 61.29 70.80 59.60 54.40 60.55 64.33
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
8.82 9.72 9.59 6.95 8.44 10.47 13.37 14.13 15.79 13.18 18.10
Cash Conversion Cycle (CCC)
55.07 55.42 55.63 49.13 46.67 50.82 57.43 45.46 38.61 47.37 46.23
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
303 307 302 297 320 205 216 209 99 88 98
Invested Capital Turnover
1.78 1.69 1.58 1.49 1.46 1.55 1.36 1.75 2.31 1.99 1.59
Increase / (Decrease) in Invested Capital
-4.14 5.44 4.37 -23 115 -11 7.29 110 11 -9.76 -2.14
Enterprise Value (EV)
1,305 1,429 882 1,682 1,382 1,051 522 522 530 334 213
Market Capitalization
1,482 1,569 980 1,791 1,444 1,070 507 513 625 427 293
Book Value per Share
$8.58 $8.11 $7.27 $7.44 $7.61 $4.46 $4.04 $4.08 $3.97 $3.80 $3.86
Tangible Book Value per Share
$3.17 $2.36 $1.47 $1.16 $0.36 ($0.10) ($0.61) ($0.48) $1.88 $1.75 $1.78
Total Capital
519 509 482 508 503 294 281 281 195 182 178
Total Debt
40 59 79 99 118 69 78 78 0.00 0.00 0.00
Total Long-Term Debt
20 40 59 79 99 59 69 78 0.00 0.00 0.00
Net Debt
-177 -143 -101 -111 -64 -20 14 6.81 -96 -94 -80
Capital Expenditures (CapEx)
2.80 2.53 2.97 2.68 2.62 11 1.91 2.62 10 8.85 7.56
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-11 -17 -21 -42 -40 -37 -5.82 -11 -6.68 -12 -3.74
Debt-free Net Working Capital (DFNWC)
205 186 159 168 142 52 59 61 72 51 44
Net Working Capital (NWC)
186 166 139 149 123 42 49 61 72 51 44
Net Nonoperating Expense (NNE)
-3.20 1.43 0.76 0.17 3.15 2.09 2.94 0.15 -0.41 -0.13 -0.12
Net Nonoperating Obligations (NNO)
-177 -143 -101 -111 -64 -20 14 6.81 -96 -94 -80
Total Depreciation and Amortization (D&A)
4.42 22 4.33 29 23 19 20 16 9.51 9.17 8.49
Debt-free, Cash-free Net Working Capital to Revenue
-2.00% -3.21% -4.45% -9.07% -10.49% -11.35% -2.01% -3.96% -3.09% -6.35% -2.37%
Debt-free Net Working Capital to Revenue
37.86% 36.06% 33.52% 36.54% 37.18% 16.03% 20.30% 22.59% 33.51% 27.66% 27.73%
Net Working Capital to Revenue
34.21% 32.22% 29.35% 32.24% 32.01% 12.99% 16.88% 22.59% 33.51% 27.66% 27.73%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.29 $1.13 $0.95 $0.86 $0.67 $0.53 $0.28 $0.01 $0.40 $0.42 $0.31
Adjusted Weighted Average Basic Shares Outstanding
55.89M 55.73M 55.14M 55.07M 54.66M 50.16M 0.00 49.76M 49.04M 48.76M 47.68M
Adjusted Diluted Earnings per Share
$1.29 $1.12 $0.95 $0.85 $0.65 $0.52 $0.28 $0.01 $0.40 $0.41 $0.30
Adjusted Weighted Average Diluted Shares Outstanding
55.89M 55.73M 55.14M 55.07M 54.66M 50.16M 0.00 49.76M 49.04M 48.76M 47.68M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
55.89M 55.73M 55.14M 55.07M 54.66M 50.16M 0.00 49.76M 49.04M 48.76M 47.68M
Normalized Net Operating Profit after Tax (NOPAT)
69 64 54 47 37 29 17 0.70 19 20 14
Normalized NOPAT Margin
12.74% 12.49% 11.31% 10.30% 9.74% 8.78% 5.85% 0.26% 8.88% 10.86% 9.18%
Pre Tax Income Margin
16.56% 14.99% 13.81% 12.43% 10.76% 10.78% 6.57% -0.75% 11.74% 13.20% 9.55%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
49.72% 45.10% 72.89% 44.96% 20.62% 42.12% 71.61% 1,771.76% 50.30% 35.78% 0.73%
Augmented Payout Ratio
49.72% 45.10% 72.89% 44.96% 20.62% 42.12% 71.61% 1,771.76% 50.30% 35.78% 0.73%

Quarterly Metrics And Ratios for Sapiens International

No quarterly metrics and ratios for Sapiens International are available.


Frequently Asked Questions About Sapiens International's Financials

When does Sapiens International's financial year end?

According to the most recent income statement we have on file, Sapiens International's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Sapiens International's net income changed over the last 10 years?

Sapiens International's net income appears to be on an upward trend, with a most recent value of $72.32 million in 2024, rising from $14.58 million in 2014. The previous period was $62.87 million in 2023. Find out what analysts predict for Sapiens International in the coming months.

What is Sapiens International's operating income?
Sapiens International's total operating income in 2024 was $85.85 million, based on the following breakdown:
  • Total Gross Profit: $238.11 million
  • Total Operating Expenses: $152.26 million
How has Sapiens International revenue changed over the last 10 years?

Over the last 10 years, Sapiens International's total revenue changed from $157.45 million in 2014 to $542.38 million in 2024, a change of 244.5%.

How much debt does Sapiens International have?

Sapiens International's total liabilities were at $212.08 million at the end of 2024, a 11.5% decrease from 2023, and a 287.3% increase since 2014.

How much cash does Sapiens International have?

In the past 10 years, Sapiens International's cash and equivalents has ranged from $47.40 million in 2014 to $190.24 million in 2021, and is currently $163.69 million as of their latest financial filing in 2024.

How has Sapiens International's book value per share changed over the last 10 years?

Over the last 10 years, Sapiens International's book value per share changed from 3.86 in 2014 to 8.58 in 2024, a change of 122.4%.



This page (NASDAQ:SPNS) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners